21st European Gynaecological Oncology Congress of the European Society of Gynaecological Oncology

Leading experts in the field will present the key findings of these important studies, summarise the results, and provide a critical appraisal of the data.
The Session will focus on:
+ PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2
+ First line ovarian cancer trials: VELIA/Forward1
+ Lessons learned from gynaecological cancer trials:
EWOC-1/EORTC55944/ PORTEC-3
The results of this research will be set in context of other trials, and how the results can influence future treatment approaches of gynaecological cancers.